Because the increase in Foxp3+ T cells in the liver-infiltrating lymphocytes of ACLF and CLF patients was not proportional with the increase in IL-17+ T cells, the Foxp3+ T cells could not negatively regulate the immune system and ultimately, this would cause liver failure. Here, FOXP3 is linked to liver failure.